Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis

Overview

Journal Front Pharmacol

Date 2022 Jul 7

PMID 35795561

Authors

Fangyuan Tian

Zhaoyan Chen

Jinhui Wu

Affiliations

Soon will be listed here.

Abstract

Polypharmacy and potentially inappropriate medication (PIM) use among elderly Chinese patients have not yet been investigated by systematic review and meta-analysis. The purposes of this study were to investigate the prevalence of polypharmacy and PIM use and the risk factors associated with PIM use in elderly Chinese patients. Databases including PubMed, EMBase, and Web of Science were searched to collect studies which used Chinese criteria, Beers criteria, or STOPP criteria to evaluate the PIM status of elderly Chinese patients from inception to August 2021 (PROSPERO Code No: CRD42021262821). Observational studies reporting the prevalence of polypharmacy and PIM use in elderly Chinese patients were meta-analyzed. The pooled prevalence and risk ratio (RR) were calculated with a 95% confidence interval (CI). A total of 8 articles involving 4,558,786 patients were included. The overall prevalence of polypharmacy (concomitant use of more than 5 medicines) and PIM use pooled by meta-analysis in Chinese older patients was 48% (95% CI: 0.17, 0.79, = 0.003) (inpatients 73%, outpatients 23%) and 39% (95% CI: 0.25, 0.54, < 0.001) (inpatients 50%, outpatients 29%), respectively. Polypharmacy (RR: 2.03, 95% CI: 1.13, 3.64) was significantly associated with PIM use. This meta-analysis demonstrated a high prevalence of polypharmacy and PIM use among elderly patients in China. Affected by the quantity and quality of the included studies, the aforementioned conclusions need to be confirmed by large samples and high-quality studies.

Citing Articles

Prevalence and Factors with Potentially Inappropriate Prescribing among Older Surgical Outpatients in China: A Nationwide Cross-sectional Study in 100 Hospitals.

Tian F, Chen Z, Zhang J, Zhang Y, Feng Q J Epidemiol Glob Health. 2025; 15(1):39.

PMID: 40072651 PMC: 11903986. DOI: 10.1007/s44197-025-00378-x.

Impact of Chinese criteria on potentially inappropriate medication use in China.

Tian F, Chen Z, Zhang Y, Feng Q, Chen X J Glob Health. 2025; 15:04063.

PMID: 39913549 PMC: 11801653. DOI: 10.7189/jogh.15.04063.

Potentially inappropriate prescribing among older adults with hypertension in China: prevalence and related comorbidities across different outpatient settings.

Chen J, Wang S, Lu L, Yang Y, Wang K, Zheng J Front Pharmacol. 2024; 15:1439230.

PMID: 39211782 PMC: 11357909. DOI: 10.3389/fphar.2024.1439230.

Potentially Inappropriate Medications Involved in Drug-Drug Interactions in a Polish Population over 80 Years Old: An Observational, Cross-Sectional Study.

Bleszynska-Marunowska E, Jagiello K, Wierucki L, Renke M, Grodzicki T, Kalarus Z Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204131 PMC: 11357612. DOI: 10.3390/ph17081026.

Pharmacist interventions in Asian healthcare environments for older people: a systematic review and meta-analysis on hospitalization, mortality, and quality of life.

Kim I, Ryu G, Rhie S, Kim H BMC Geriatr. 2024; 24(1):513.

PMID: 38867148 PMC: 11170896. DOI: 10.1186/s12877-024-05089-9.

References

Bhagavathula A, Gebreyohannes E, Fialova D . Prevalence of Polypharmacy and Risks of Potentially Inappropriate Medication Use in the Older Population in a Developing Country: A Systematic Review and Meta-Analysis. Gerontology. 2021; 68(2):136-145. DOI: 10.1159/000516075. View

OMahony D . STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2019; 13(1):15-22. DOI: 10.1080/17512433.2020.1697676. View

Nam Y, Han J, Kim J, Bae W, Lee K . Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study. BMC Geriatr. 2016; 16:118. PMC: 4890525. DOI: 10.1186/s12877-016-0285-3. View

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

Fu M, Wushouer H, Nie X, Shi L, Guan X, Ross-Degnan D . Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China. Pharmacoepidemiol Drug Saf. 2020; 29(8):923-930. DOI: 10.1002/pds.5064. View

Scott I, Hilmer S, Reeve E, Potter K, Le Couteur D, Rigby D . Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015; 175(5):827-34. DOI: 10.1001/jamainternmed.2015.0324. View

Amano H, Fujimoto K, Fujimori M, Saka N, Nomura K, Tanihara S . The Prevalence and Characteristics of Older Japanese Adults with Polypharmacy, Based on Regionally Representative Health Insurance Claims Data. Acta Med Okayama. 2020; 74(1):41-48. DOI: 10.18926/AMO/57951. View

Al-Azayzih A, Alamoori R, Altawalbeh S . Potentially inappropriate medications prescribing according to Beers criteria among elderly outpatients in Jordan: a cross sectional study. Pharm Pract (Granada). 2019; 17(2):1439. PMC: 6594439. DOI: 10.18549/PharmPract.2019.2.1439. View

Tian F, Li H, Chen Z, Xu T . Potentially inappropriate medications in Chinese older outpatients in tertiary hospitals according to Beers criteria: A cross-sectional study. Int J Clin Pract. 2021; 75(8):e14348. DOI: 10.1111/ijcp.14348. View

10.

Cojutti P, Arnoldo L, Cattani G, Brusaferro S, Pea F . Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very.... Pharmacoepidemiol Drug Saf. 2016; 25(9):1070-8. DOI: 10.1002/pds.4026. View

11.

Tian F, Liao S, Chen Z, Xu T . The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study. Ann Transl Med. 2021; 9(18):1483. PMC: 8506761. DOI: 10.21037/atm-21-4238. View

12.

Liew T, Lee C, Goh S, Chang Z . The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings: multilevel meta-analysis. Age Ageing. 2020; 49(4):570-579. DOI: 10.1093/ageing/afaa057. View

13.

Chen C, Hu Z, Jiang Z, Zhou F . Prevalence of anxiety in patients with mild cognitive impairment: A systematic review and meta-analysis. J Affect Disord. 2018; 236:211-221. DOI: 10.1016/j.jad.2018.04.110. View

14.

Midao L, Giardini A, Menditto E, Kardas P, Costa E . Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018; 78:213-220. DOI: 10.1016/j.archger.2018.06.018. View

15.

Hu J, Dong Y, Chen X, Liu Y, Ma D, Liu X . Prevalence of suicide attempts among Chinese adolescents: A meta-analysis of cross-sectional studies. Compr Psychiatry. 2015; 61:78-89. DOI: 10.1016/j.comppsych.2015.05.001. View

16.

Achterhof A, Rozsnyai Z, Reeve E, Jungo K, Floriani C, Poortvliet R . Potentially inappropriate medication and attitudes of older adults towards deprescribing. PLoS One. 2020; 15(10):e0240463. PMC: 7588126. DOI: 10.1371/journal.pone.0240463. View

17.

Stuhec M . Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm. 2021; 43(6):1722-1727. DOI: 10.1007/s11096-021-01306-2. View

18.

Wu H, Kouladjian Odonnell L, Fujita K, Masnoon N, Hilmer S . Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions. Int J Gen Med. 2021; 14:3793-3807. PMC: 8317936. DOI: 10.2147/IJGM.S253177. View

19.

Rieckert A, Reeves D, Altiner A, Drewelow E, Esmail A, Flamm M . Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomised controlled trial. BMJ. 2020; 369:m1822. PMC: 7301164. DOI: 10.1136/bmj.m1822. View

20.

Mohamed M, Ramsdale E, Loh K, Arastu A, Xu H, Obrecht S . Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis. Oncologist. 2019; 25(1):e94-e108. PMC: 6964156. DOI: 10.1634/theoncologist.2019-0406. View